Healthcare Digitalization Fuels Provider Lifecycle Management

According to the latest market research study published by P&S Intelligence, the global provider lifecycle management market is projected to experience substantial growth, with an estimated valuation of USD 1,493.6 million in 2023, expected to reach USD 3,964.6 million by 2030, reflecting a compound annual growth rate (CAGR) of 15.2% during the forecast period.

This growth is primarily driven by the increasing burden of chronic diseases and the adoption of sedentary lifestyles, leading to higher hospitalization rates. Consequently, healthcare providers are seeking efficient solutions to manage the escalating workload, thereby boosting the adoption of provider lifecycle management systems. Additionally, significant government investments in healthcare infrastructure aim to improve patient care quality, further propelling market expansion.

Download Free Report Sample Now

Key Insights

Segmentation Analysis:​

By Solution: The market encompasses various solutions, including recruitment, credentialing, online application, contracting, data management, and finder services. Among these, credentialing solutions hold a significant share due to the critical need for verifying healthcare providers' qualifications and ensuring compliance with regulatory standards.

Regional and Geographical Trends:​

North America: This region leads the market, attributed to advanced healthcare infrastructure, early adoption of digital technologies, and stringent regulatory requirements necessitating efficient provider management systems.​

Asia-Pacific: The fastest-growing region, driven by increasing healthcare investments, a burgeoning patient population, and a growing emphasis on enhancing healthcare delivery efficiency. ​

Technological Advancements Shaping the Market:​

Artificial Intelligence (AI): The integration of AI in provider lifecycle management solutions enhances data accuracy, reduces administrative burdens, and streamlines processes such as credentialing and recruitment.​

Real-Time Data Access: The demand for real-time data and analytics is rising, enabling healthcare institutions to monitor and improve operations efficiently. For instance, platforms like Infosys's Helix Credentialing module authenticate and validate provider information in real time, reducing manual efforts and time consumption. ​

Competitive Dynamics, Major Players, and Emerging Opportunities:​

Key Players: The market features prominent companies such as Infosys, which offers advanced credentialing modules, and other technology firms providing comprehensive provider lifecycle management solutions.​

Emerging Opportunities: The ongoing digitalization of the healthcare sector presents significant opportunities for market players to develop innovative solutions that enhance interoperability, streamline workflows, and improve patient care quality. Additionally, the increasing focus on reducing clinical errors and optimizing resource utilization drives the demand for advanced provider lifecycle management systems. ​

In conclusion, the provider lifecycle management market is poised for robust growth, driven by technological advancements, regional healthcare developments, and the pressing need for efficient provider management solutions in the evolving healthcare landscape.

Read More

Breast Lesion Localization - Industry Development and Future Analysis

In 2023, the worldwide market for breast lesion localization was assessed at USD 410.4 million. Projections indicate a growth to USD 653.1 million by 2030, with a compound annual growth rate (CAGR) of 7.0% expected between 2024 and 2030.

This growth of the market can be credited to the increasing breast cancer screening programs and better repayment situations. Furthermore, breast cancer is quite common illness in women and its occurrence is increasing quickly. For example, as per the data issued by the International Agency for Research on Cancer (IARC), breast cancer has now exceeded lung cancer as the most regularly identified cancer globally.

The acceptance of breast lesion localization devices will surge in the coming few years, because of the increasing occurrence of mammary cancer. The lymph nodes underneath the arms are the most typical first recognizable site of breast cancer spread; however, there are few lesions in these nodes that cannot be felt by touch. Furthermore, the malignancy might also spread to other parts of the body.

On the basis of biopsy technique, the CNB category had the largest industry share, of 35%, in 2023. This is mainly credited to its accurateness in the analysis of benign lesions and its ablity to discriminate between in-situ lesions and invasive cancer. Furthermore, CNB is certainly more dependable than fine needle aspiration since it gets a larger tissue sample and offers some architectural information.

On a global scale, North America holds the predominant market share, primarily attributed to the presence of a robust healthcare infrastructure, significant manufacturing entities, heightened awareness regarding early breast cancer detection, streamlined FDA approval procedures, and widespread adoption of advanced medical devices in cancer treatment facilities within the region.

Read More